drugset / Trial / NCT00805415

Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens

NCT00805415

Phase 2 Completed 209 enrolled Bayer
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to investigate the ovulation inhibition of two 4-phasic oral contraceptive regimens.

Timeline

Start
2003-03
Primary completion
2004-02
Completion
2004-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Dienogest Small molecule 3 mg Oral
Subject estradiol valerate Unknown 2 mg Oral

Indications